It would certainly make a great news headline...Small Biotech Left Out Of First Round of Funding Awarded Millions in Gov Grants. It would help to get some coverage beyond the geriatric radio circuit. Next few months should get interesting.

Any guesses on year end share prices of GNBT and NGIO with a vaccine in completed phase 3, revenues from RPM, and Excellegan moving forward in the VA?